Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bellerophon Therapeutics, Inc. (BLPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.9000-0.1200 (-2.99%)
At close: 4:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/13/2021
Current
6/30/20213/31/202112/31/20209/30/2020
Market Cap (intraday) 5
36.69M46.01M49.34M63.31M96.69M
Enterprise Value 3
3.71M7.83M3.44M11.16M39.37M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
1.221.391.291.381.81
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 7
-0.13-1.51-0.59-1.32-4.78

Trading Information

Stock Price History

Beta (5Y Monthly) -0.50
52-Week Change 3-57.65%
S&P500 52-Week Change 330.48%
52 Week High 39.7500
52 Week Low 33.6600
50-Day Moving Average 33.9780
200-Day Moving Average 34.2990

Share Statistics

Avg Vol (3 month) 350.41k
Avg Vol (10 day) 371.6k
Shares Outstanding 59.51M
Implied Shares Outstanding 6N/A
Float 86.99M
% Held by Insiders 14.04%
% Held by Institutions 132.90%
Shares Short (Sep 29, 2021) 454.5k
Short Ratio (Sep 29, 2021) 41.75
Short % of Float (Sep 29, 2021) 40.69%
Short % of Shares Outstanding (Sep 29, 2021) 40.57%
Shares Short (prior month Aug 30, 2021) 467.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Feb 09, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Feb 09, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.97%
Return on Equity (ttm)-59.37%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -22.2M
Net Income Avi to Common (ttm)-24.79M
Diluted EPS (ttm)-2.6080
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)34.3M
Total Cash Per Share (mrq)3.61
Total Debt (mrq)1.31M
Total Debt/Equity (mrq)4.37
Current Ratio (mrq)5.67
Book Value Per Share (mrq)3.17

Cash Flow Statement

Operating Cash Flow (ttm)-24.58M
Levered Free Cash Flow (ttm)-12.76M
Advertisement
Advertisement